Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 4
2005 5
2006 5
2007 2
2008 4
2009 4
2010 5
2011 3
2012 1
2013 7
2014 5
2015 4
2016 6
2017 3
2018 9
2019 6
2020 7
2021 3
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic Neurons.
Fasciani I, Petragnano F, Bono F, Aloisi G, Mutti V, Pardini C, Carli M, Scarselli M, Vaglini F, Angelucci A, Fiorentini C, Lozzi L, Missale C, Maggio R, Rossi M. Fasciani I, et al. Among authors: angelucci a. Neuroscience. 2024 Apr 19;544:104-116. doi: 10.1016/j.neuroscience.2024.01.009. Epub 2024 Jan 18. Neuroscience. 2024. PMID: 38244669 Free article.
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatment.
Di Maria S, Picarazzi F, Mori M, Cianciusi A, Carbone A, Crespan E, Perini C, Sabetta S, Deplano S, Poggialini F, Molinari A, Aronne R, Maccioni E, Maga G, Angelucci A, Schenone S, Musumeci F, Dreassi E. Di Maria S, et al. Among authors: angelucci a. Bioorg Chem. 2022 Nov;128:106071. doi: 10.1016/j.bioorg.2022.106071. Epub 2022 Aug 1. Bioorg Chem. 2022. PMID: 35932498
NF-κB: A Druggable Target in Acute Myeloid Leukemia.
Di Francesco B, Verzella D, Capece D, Vecchiotti D, Di Vito Nolfi M, Flati I, Cornice J, Di Padova M, Angelucci A, Alesse E, Zazzeroni F. Di Francesco B, et al. Among authors: angelucci a. Cancers (Basel). 2022 Jul 21;14(14):3557. doi: 10.3390/cancers14143557. Cancers (Basel). 2022. PMID: 35884618 Free PMC article. Review.
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6.
Ruscitti P, Liakouli V, Panzera N, Angelucci A, Berardicurti O, Di Nino E, Navarini L, Vomero M, Ursini F, Mauro D, Dolo V, Ciccia F, Giacomelli R, Cipriani P. Ruscitti P, et al. Among authors: angelucci a. Pharmaceuticals (Basel). 2022 May 18;15(5):622. doi: 10.3390/ph15050622. Pharmaceuticals (Basel). 2022. PMID: 35631449 Free PMC article.
The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma.
Rango E, Pastorino F, Brignole C, Mancini A, Poggialini F, Di Maria S, Zamperini C, Iovenitti G, Fallacara AL, Sabetta S, Clementi L, Valoti M, Schenone S, Angelucci A, Ponzoni M, Dreassi E, Botta M. Rango E, et al. Among authors: angelucci a. Biomedicines. 2022 Mar 12;10(3):659. doi: 10.3390/biomedicines10030659. Biomedicines. 2022. PMID: 35327462 Free PMC article.
Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models.
Brai A, Riva V, Clementi L, Falsitta L, Zamperini C, Sinigiani V, Festuccia C, Sabetta S, Aiello D, Roselli C, Garbelli A, Trivisani CI, Maccari L, Bugli F, Sanguinetti M, Calandro P, Chiariello M, Quaranta P, Botta L, Angelucci A, Maga G, Botta M. Brai A, et al. Among authors: angelucci a. Cancers (Basel). 2021 Nov 7;13(21):5569. doi: 10.3390/cancers13215569. Cancers (Basel). 2021. PMID: 34771731 Free PMC article.
92 results